Drug: endoxan Quarter: 2016Q3
Total Drug/Injury Combinations: 404 Number of Pages: 21
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| ENDOXAN BAXTER | Primary mediastinal large B-cell lymphoma recurrent | 1 | view events |
| ENDOXAN BAXTER | Rash | 1 | view events |
| ENDOXAN BAXTER | Salivary hypersecretion | 1 | view events |
| Endoxan Baxter | Troponin increased | 1 | view events |
| ENDOXAN CYCLOPHOSPHAMIDE 2G (AS MONOHYDRATE) POWDER FOR INJECTION VIAL | Arthritis | 1 | view events |
| ENDOXAN CYCLOPHOSPHAMIDE 2G (AS MONOHYDRATE) POWDER FOR INJECTION VIAL | Drug ineffective | 1 | view events |
| Endoxan Lyophilisat | Haematotoxicity | 1 | view events |
| Endoxan Lyophilisat | Mania | 1 | view events |
| Endoxan Lyophilisat | Pulmonary hypertension | 1 | view events |
| Endoxan Lyophilisat | Renal impairment | 1 | view events |
| Endoxan Lyophilisat | Thrombotic microangiopathy | 1 | view events |
| Endoxan Lyophilisat | White blood cell count decreased | 1 | view events |
| ENDOXAN VIAL 1G | Laryngospasm | 1 | view events |
| ENDOXAN ^BAXTER^ 1G - TROCKENSTECHAMPULLE | Cardiac failure | 1 | view events |
| ENDOXAN ^BAXTER^ 1G - TROCKENSTECHAMPULLE | Mitral valve incompetence | 1 | view events |
| ENDOXAN-1G | Non-small cell lung cancer | 1 | view events |
| ENDOXAN-1G | Pneumonia | 1 | view events |
| ENDOXAN-BAXTER | Cardiotoxicity | 1 | view events |
| ENDOXAN-BAXTER | Chest pain | 1 | view events |
| ENDOXAN-BAXTER | Pancreatitis acute | 1 | view events |
Total Drug/Injury Combinations: 404 Number of Pages: 21
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)